JP Morgan Chase’s NexImmune, Inc. Common Stock NEXI Stock Holding History

JP Morgan Chase’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,000	Closed	-$11.1K	–	7824
2024 Q2	$11.1K	Buy	+4,000	New	+$13.5K	﹤0.01%	6240
2022 Q2	–	Sell	-10,213	Closed	-$1.07M	–	7000
2022 Q1	$1.07M	Sell	10,213 -367	-3%	-$26.9K	﹤0.01%	4208
2021 Q4	$1.22M	Sell	10,580 -151	-1%	-$36.3K	﹤0.01%	4237
2021 Q3	$4.06M	Sell	10,731 -206	-2%	-$69.1K	﹤0.01%	3205
2021 Q2	$4.46M	Buy	10,937 +4,471	+69%	+$2.06M	﹤0.01%	3154
2021 Q1	$3.08M	Buy	+6,466	New	+$3.52M	﹤0.01%	3372

Other funds holding NEXI

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

JP Morgan Chase's NEXI Position: Q3 2024 in Review

JP Morgan Chase sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2024, closing a stake of 4,000 shares — an estimated $11.1K sold.

JP Morgan Chase first reported a position in NEXI in Q1 2021 and held it in 6 quarters. The position peaked at $4.46M in Q2 2021. 1 fund tracked by Wall St. Rank holds NEXI as of Q3 2024.

JP Morgan Chase reported no remaining NexImmune, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
JP Morgan Chase sold 4,000 NexImmune, Inc. Common Stock shares in Q3 2024, an estimated $11.1K.
JP Morgan Chase first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
JP Morgan Chase's NexImmune, Inc. Common Stock position peaked at $4.46M in Q2 2021.
1 fund tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.